Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Masafumi Sata
Osimertinib, a Third‐generation EGFR Tyrosine Kinase Inhibitor: A Retrospective Multicenter Study of Its Real‐world Efficacy and Safety in Advanced/Recurrent Non‐small Cell Lung Carcinoma
Thoracic Cancer
Medicine
Pulmonary
Respiratory Medicine
Oncology